126 related articles for article (PubMed ID: 8954349)
21. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.
Peeters CC; Tenbergen-Meekes AM; Evenberg DE; Poolman JT; Zegers BJ; Rijkers GT
J Immunol; 1991 Jun; 146(12):4308-14. PubMed ID: 2040803
[TBL] [Abstract][Full Text] [Related]
22. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.
Appelmelk BJ; Maaskant JJ; Verweij-van Vught AM; van der Meer NM; Thijs BG; MacLaren DM
J Gen Microbiol; 1993 Nov; 139(11):2641-7. PubMed ID: 7506295
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the Shigella serotype D (S. sonnei) O polysaccharide and the enterobacterial R1 lipopolysaccharide core by use of mouse monoclonal antibodies.
Viret JF; Bruderer U; Lang AB
Infect Immun; 1992 Jul; 60(7):2741-7. PubMed ID: 1612742
[TBL] [Abstract][Full Text] [Related]
24. Antibodies against core and O antigen epitopes of Escherichia coli O83 in rabbit antisera and in commercial human immunoglobulin.
Orskov F; Orskov I
Med Microbiol Immunol; 1991; 180(3):157-66. PubMed ID: 1717815
[TBL] [Abstract][Full Text] [Related]
25. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.
Paoletti LC; Kasper DL; Michon F; DiFabio J; Jennings HJ; Tosteson TD; Wessels MR
J Clin Invest; 1992 Jan; 89(1):203-9. PubMed ID: 1729272
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.
Verheul AF; Braat AK; Leenhouts JM; Hoogerhout P; Poolman JT; Snippe H; Verhoef J
Infect Immun; 1991 Mar; 59(3):843-51. PubMed ID: 1900063
[TBL] [Abstract][Full Text] [Related]
27. Variation in Salmonella core lipopolysaccharide as detected by the monoclonal antibody M105.
Mansfield LP; Billett E; Olsen E; Forsythe SJ
Lett Appl Microbiol; 1996 Aug; 23(2):104-6. PubMed ID: 8987449
[TBL] [Abstract][Full Text] [Related]
28. Antibodies against bacterial lipopolysaccharides in Japanese patients with ankylosing spondylitis.
Tani Y; Sato H; Tanaka N; Hukuda S
Br J Rheumatol; 1997 Apr; 36(4):491-3. PubMed ID: 9159547
[TBL] [Abstract][Full Text] [Related]
29. Determination of specificities of rabbit antisera against the O-antigenic polysaccharide from Escherichia coli O126.
Bhattacharyya T; Basu S
FEMS Immunol Med Microbiol; 1994 Nov; 10(1):19-24. PubMed ID: 7533024
[TBL] [Abstract][Full Text] [Related]
30. Serological relationships of the O antigens of Klebsiella pneumoniae O5, Escherichia coli O8 and a new O serotype of Serratia marcescens.
Aucken HM; Pitt TL
FEMS Microbiol Lett; 1991 May; 64(1):93-7. PubMed ID: 1713181
[TBL] [Abstract][Full Text] [Related]
31. Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis.
Jennings HJ; Lugowski C; Ashton FE
Infect Immun; 1984 Jan; 43(1):407-12. PubMed ID: 6418661
[TBL] [Abstract][Full Text] [Related]
32. Enzyme immunoassay for the quantitation of immunoglobulin M class antibodies to Salmonella minnesota R595 and Escherichia coli J5 lipopolysaccharides.
Vanesian MA; Fung G; Bagdasarian A
Diagn Microbiol Infect Dis; 1987 Jan; 6(1):11-25. PubMed ID: 3542358
[TBL] [Abstract][Full Text] [Related]
33. Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae.
Ito JI; Wunderlich AC; Lyons J; Davis CE; Guiney DG; Braude AI
J Infect Dis; 1980 Oct; 142(4):532-7. PubMed ID: 6777436
[TBL] [Abstract][Full Text] [Related]
34. Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.
Polotsky VY; Robbins JB; Bryla D; Schneerson R
Infect Immun; 1994 Jan; 62(1):210-4. PubMed ID: 8262629
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of neutralization of endotoxin by monoclonal antibodies to O and R determinants of lipopolysaccharide.
Sagawa T; Hitsumoto Y; Kanoh M; Utsumi S; Kimura S
Adv Exp Med Biol; 1990; 256():341-4. PubMed ID: 2183557
[No Abstract] [Full Text] [Related]
36. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
Jennings HJ; Lugowski C
J Immunol; 1981 Sep; 127(3):1011-8. PubMed ID: 6790606
[TBL] [Abstract][Full Text] [Related]
37. Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate.
Niedziela T; Letowska I; Lukasiewicz J; Kaszowska M; Czarnecka A; Kenne L; Lugowski C
Infect Immun; 2005 Nov; 73(11):7381-9. PubMed ID: 16239537
[TBL] [Abstract][Full Text] [Related]
38. Characterization of murine monoclonal antibodies to Escherichia coli J5.
Miner KM; Manyak CL; Williams E; Jackson J; Jewell M; Gammon MT; Ehrenfreund C; Hayes E; Callahan LT; Zweerink H
Infect Immun; 1986 Apr; 52(1):56-62. PubMed ID: 3514463
[TBL] [Abstract][Full Text] [Related]
39. Cross-reactivity between six Enterobacteriaceae complete lipopolysaccharide core chemotypes.
Nnalue NA; Khan GN; Mustafa N
J Med Microbiol; 1999 May; 48(5):433-441. PubMed ID: 10229540
[TBL] [Abstract][Full Text] [Related]
40. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
